Global Aesthetics Injectables Market Size Likely to Surpass at a CAGR of 9.8% By 2033

As per the current market research conducted by the CMI Team, the global Aesthetics Injectables Market size is expected to record a CAGR of 9.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 15,509.4 Million. By 2033, the valuation is anticipated to reach USD 35,976.2 Million.

Aesthetics Injectables Market: Growth Factors and Dynamics

• Increasing Aging Population: The growing aging population globally drives demand for aesthetics injectables as individuals seek non-invasive procedures to address signs of aging such as wrinkles, fine lines, and volume loss, stimulating market growth.

• Rising Beauty Consciousness: Growing beauty consciousness, fueled by social media influence and the desire for youthful appearances, encourages individuals to opt for aesthetic procedures, contributing to the expansion of the aesthetics injectables market.

• Technological Advancements: Continuous technological advancements in injectable formulations and delivery techniques enhance safety, efficacy, and patient satisfaction, attracting more consumers and expanding the market scope.

• Expanding Acceptance: Increasing acceptance of aesthetics injectables as mainstream cosmetic treatments, coupled with reduced stigma associated with cosmetic procedures, drives higher adoption rates and market growth.

• Emergence of Minimally Invasive Procedures: Preference for minimally invasive or non-surgical procedures with minimal downtime and fewer risks fuels the demand for aesthetics injectables as alternatives to invasive surgeries, propelling the market growth.

• Growing Disposable Income: Rising disposable income levels, especially in emerging economies, enable more individuals to afford aesthetics injectables, leading to increased consumer spending on cosmetic procedures and driving market expansion.

• Shift towards Preventive Aesthetics: Increasingly, individuals are opting for preventive aesthetics injectables at younger ages to delay signs of aging rather than waiting for them to become more pronounced. This trend drives market growth as it expands the target demographic for aesthetics injectables beyond those seeking corrective procedures.

• Medical Tourism: The rise of medical tourism, particularly in countries offering high-quality aesthetic procedures at lower costs, contributes to market growth by attracting patients from around the world seeking affordable and quality aesthetics injectable treatments.

• Regulatory Approvals and Safety: Stringent regulatory approvals for aesthetics injectables ensure product safety and efficacy, fostering consumer confidence and driving market growth. Continued emphasis on patient safety and regulation compliance promotes trust in the industry and encourages more individuals to consider aesthetics injectables as a viable cosmetic option.

Aesthetics Injectables Market: Partnership and Acquisitions

• In 2022, Under its Allergan Aesthetics division, Allergan launched Juvéderm VOLUX in India, expanding its market presence and reaching previously untapped economies. This strategic move enables Allergan to attract new customers and capitalize on the growing demand for aesthetic injectables in India.

• In 2021, Sinclair Pharma granted Galderma SA exclusive distribution partnership rights for Sculptra, a poly-l-lactic acid injectable, in Europe. This strategic collaboration enhances Galderma’s product portfolio and market presence in the region, while Sinclair Pharma leverages Galderma’s extensive distribution network for increased market reach.

Report Scope

Aesthetics Injectables Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Aesthetics Injectables Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Temporary Clinic Closures: During the pandemic, many aesthetics clinics were temporarily closed or operated at reduced capacity due to lockdowns and social distancing measures, leading to a significant decline in aesthetics injectables procedures.

• Decreased Consumer Spending: Economic uncertainties and reduced disposable income caused by the pandemic led to a decrease in consumer spending on non-essential services, including aesthetics injectables treatments, further impacting market demand.

• Pent-Up Demand: As restrictions ease and consumer confidence returns, pent-up demand for aesthetics injectables procedures is expected to drive a surge in appointments and treatments, leading to a rapid recovery in market demand.

• Promotional Offers and Discounts: Aesthetics clinics may offer promotional discounts and special offers to incentivize patients to undergo injectables treatments, stimulating demand and encouraging hesitant consumers to book appointments.

• Focus on Safety and Hygiene: Aesthetics clinics are implementing stringent safety and hygiene protocols to reassure patients and mitigate concerns about COVID-19 transmission, fostering trust and confidence in the safety of injectables procedures.

• Introduction of Teleconsultations: To maintain patient engagement and attract new clients, aesthetics clinics are offering teleconsultations for initial assessments and treatment planning, providing convenience and accessibility while adhering to social distancing guidelines.

• Innovative Marketing Strategies: Aesthetics injectables providers are leveraging digital marketing platforms and social media channels to engage with consumers, showcase treatment results, and educate patients about the safety and benefits of injectables procedures, driving demand and recovery in the market.

• Expansion of Service Offerings: Aesthetics clinics may diversify their service offerings to include complementary treatments such as skin care services, wellness therapies, or combination procedures, catering to evolving consumer preferences and maximizing revenue streams as the market recovers from the impact of COVID-19.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Aesthetics Injectables Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Aesthetics Injectables Market:

• Allergan plc (now part of AbbVie)
• Galderma S.A.
• Merz Pharma GmbH & Co. KGaA
• Sinclair Pharma plc
• Suneva Medical Inc.
• Teoxane Laboratories
• Anika Therapeutics Inc.
• Prollenium Medical Technologies Inc.
• Luminera Derm Ltd.
• Revance Therapeutics Inc.
• Ipsen Pharma
• Laboratoires Vivacy SAS
• SciVision Biotech Inc.
• Merz Aesthetics Inc.
• AQTIS Medical BV
• Others

The Aesthetics Injectables Market is segmented as follows:

By Product Type

• Botulinum Toxin
• Dermal Fillers
• Collagen Stimulators
• Others

By Application

• Facial Line Correction
• Lip Augmentation
• Facial Volume Restoration
• Wrinkle Reduction
• Others

By Gender

• Male
• Female

By End-User

• Hospitals
• Dermatology Clinics
• Cosmetic Centers
• Ambulatory Surgical Centers
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America